pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 2
MP-0712
Neuroendocrine Tumors
$MOLN
MOLECULAR PARTNERS AG
Phase 2
MP-101
dimiracetam [INN]
Amyotrophic Lateral Sclerosis
Mitochon Pharmaceuticals Inc
Phase 2
MP-1032
Coronavirus Disease 2019 (COVID-19)
MetrioPharm AG
Phase 2
← prev
page 125 of 271
next →
Pain
89
Neurology
1
MPB-1734
Solid Tumor
MegaPro Biomedical Co Ltd
Preclinical
MPB-2354
Rheumatoid Arthritis
MegaPro Biomedical Co Ltd
Phase 3
MPC-06ID
rexlemestrocel-L
Chronic Low Back Pain (CLBP)
$MESO
MESOBLAST LTD
pre_registration
MR-107A02
meloxicam
Post-Operative Pain
$VTRS
Viatris Inc
Phase 3
MR-142
phentolamine mesylate
Nyctalopia (Night Blindness)
$VTRS
Viatris Inc
Phase 2
MRG-002
Gastric Cancer
Shanghai Miracogen Inc
Phase 2
MRG-004A
Solid Tumor
Shanghai Miracogen Inc
Phase 2
MRM-3379
Fragile X Syndrome
$MIRM
Mirum Pharmaceuticals, Inc.
Phase 2
MRT-2359
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$GLUE
Monte Rosa Therapeutics, Inc.
Phase 1
MRT-6160
Axial Spondyloarthritis
$NVS
NOVARTIS AG
Phase 1
MRT-8102
Inflammation
$GLUE
Monte Rosa Therapeutics, Inc.
Phase 1
MRX-2843
Non-Small Cell Lung Cancer
Meryx Inc
Phase 1
MRX-8
Acinetobacter Infections
MicuRx Pharmaceuticals Inc
MS CONTIN
MS CONTIN (MORPHINE SULFATE)
no indication
Purdue Pharma LP
Preclinical
MSC-2
Optic Neuritis
SanBio Co Ltd
Preclinical
MSCKD
Acute Renal Failure (ARF) (Acute Kidney Injury)
Orgenesis Inc
Phase 1
MT-101
Parkinson's Disease
MThera Pharma Co Ltd
Phase 2
MT-125
Glioblastoma Multiforme (GBM)
Myosin Therapeutics Inc
Phase 2
MT-2990
Endometriosis
Tanabe Pharma Corp
Phase 2
MTG-201
Prostate Cancer
Momotaro-Gene Inc
Phase 1
MTI-201
Metastatic Uveal Melanoma
Modulation Therapeutics Inc
Phase 2
MTL-CEBPA
Hepatocellular Carcinoma
Mina Therapeutics Ltd
Phase 2
MTX-001
Venous Leg Ulcers (Crural Ulcer)
Merakris Therapeutics Inc
Phase 2
MTX-463
Idiopathic Pulmonary Fibrosis
Eli Lilly and Co
Phase 2
MTX-652
Acute Renal Failure (ARF) (Acute Kidney Injury)
Mission Therapeutics Ltd
MUCINEX DM MAXIMUM STRENGTH
MUCINEX DM MAXIMUM STRENGTH (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE)
no indication
RB HLTH
MUCUS DM
MUCUS DM (DEXTROMETHORPHAN HBR, GUAIFENESIN)
no indication
PERRIGO R AND D
